Achieve Life Sciences announced that the Data Safety Monitoring Committee reviewed its ORCA-OL trial and found no unexpected adverse events, allowing the study to continue as planned.
AI Assistant
ACHIEVE LIFE SCIENCES INC
2025
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.